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INTRODUCTION 
Diabetes mellitus consists of a group of syndrome 
characterized by hyperglycemia, altered metabolis m of 
lip ids, carbohydrates, and proteins; resulting from defects 
in insulin secretion, its action, or both 
1.
 It is a chronic 
metabolic disorder which affects a significant population 
worldwide 
2
. The total number of people globally affected 
by diabetes was reported to be 171 million in 2000 and is 
projected to be 366 million by 2030 with a prevalence rate 
of 4.4 percent 
3
.
 
Greatest number of cases being expected 
in China and India. 
It is a major cause of morbidity and mortality.  Present 
drugs which are used for the treatment of this disease are 
mainly insulin, sulphonylureas and biguanides. All these 
drugs are associated with adverse effect and not able to 
control metabolism adequately. Management of diabetes 
with agents devoid of any side effects is still a challenge to 
the medical system. There is growing interest in herbal 
remedies due to these reasons  
4
. 
From ancient time plant species are used in the treatment 
of various diseases. It is an important ingredient in  
traditional medicine. But yet only about five percent of the 
total plant species has been thoroughly tested for its safety 
and efficacy.         
H. antidysenterica commonly known as kurci, kurch i or 
kutaj is one of the important medicinal herbs of the family  
Apocynaceae. Its seed is known as Indrayava or indrajab 
plays a major role as an ingredient in Ayurvedic 
prescriptions for flatulence, jaundice, p iles and worms.      
Its bark is being used from ancient time in the treatment of 
amoebiasis, in chronic bronchitis and locally for bo ils and 
ulcers. 
Recent study reflects the use of these traditional medicinal 
plants against malaria
5
, mult iple antibiot ic resistant 
enteropathogenic E. co li and in gut motility disorder
6, 7
. 
There are few studies of different parts of this plant related 
to its hypoglycemic effect. Fifty percent ethanolic extract  
of fruit has shown hypoglycemic activ ity in rats
8
. Aqueous 
and alcoholic extract of its bark has reversed the 
hyperglycemic condit ion produced by streptozotocin 
injection
9
. Scientific data related to the antidiabetic 
efficacy of ethanolic ext ract of its seed in diabetic rats is 
lacking.  
The purpose of this study was to investigate the efficacy of 
ethanolic extract of H. antidysenterica seeds in STZ – 
induced diabetic rats and evaluating its effect in blood 
cholesterol, total protein, alkaline phosphatase, aspartate 
trassaminase, alanine trassaminase, urea, creatin ine and 
uric acid. 
MATERIALS AND METHODS  
H. antidysenterica seed were collected from the local 
market of Ranchi. Voucher specimens were deposited in 
the department of botany, Ranchi College Ranchi, of 
Ranchi University (voucher no. RIMS/15111/01). 
Taxonomist of this Department confirmed its identity.  
Plant extract preparation 
The seed were washed and dried in the shade. It was 
powdered in the grinder. Ethanolic ext ract (with 90% 
ethanol) of it were made in the soxhlet apparatus. The 
extract was concentrated in evaporator under reduced 
presser at 40˚C. The extract was stored at 0-4˚C. 
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Experimental animals 
Permission for the study was taken from institutional 
animal ethics committee. Healthy albino rats of either sex 
of 2-2½ months old of body weight 125-150g were housed 
in polypropylene cages at 25±2˚C with light dark cycle of 
12 hours. It was acclimat ized for seven days. All animals 
were g iven standard rat feed and water ad lib itum. 
Drugs and chemicals used 
Glibenclamide, streptozotocin and sodium citrate buffer 
were used in this study. The chemicals used in this study 
were of laboratory grade. 
Acute toxicity test 
Acute oral toxicity for the ethanolic ext ract of H. 
antidysenterica seed (EHA) was carried out on the basis of 
OECD guideline 425. The dose of the drug was 
administered by calculating the weight; as 3000 mg/kg  
body weight. At first a single animal was tested. It was 
observed carefully to watch mortality and toxicity for 24 
hours. Thereafter four other animals were also given EHA 
according to their body weight subsequently. The animals 
were marked and housed individually in cages.  Animal 
were watched for 14 days. No animal died in this period. 
Therefore, the LD50 is greater than 3000 mg/kg
10
.  
Oral glucose tolerance test 
Oral glucose tolerance test
11
 was done in overnight (18 
hour) fasted rats. Rats were divided into four groups (N=6) 
and distilled water (10 ml/kg), EHA (300 and 600mg/kg b. 
w.), g libenclamide (5mg/kg) were administered with 
glucose (2g/kg b.w).  Blood was drown from the tip of the 
tail at 0, ½, 1 and 2 hr. interval and blood glucose level 
was estimated with the help of glucometer using strip 
method (ascensia entrust,bayer pharma).     
Antidiabetic study  
Diabetes was induced in overnight fasted rat by single 
intraperitoneal inject ion of freshly prepared streptozotocin 
(Sisco research laboratory) dissolved in 0.1 M ice cold 
sodium citrate buffer of pH 4.4 at a dose of 40 mg/kg b.w. 
Ten percent glucose solution were allowed to overcome 
the drug–induced hypoglycemia. 3rd day plas ma g lucose 
level of each rat was determined for confirmation of 
diabetes. Rats with plasma glucose level above 300 mg/dl 
were considered as a diabetic and used subsequently for 
further study.  
Rats were div ided into four groups, each group having six 
animals. Group 1 served as diabetic control and received 
distilled water 10 ml/kg b.w. Group 2nd and 3rd received 
ethanolic extract of H. antidysenterica at a dose of 
300mg/kg and 600mg/kg b.w, p.o respectively. Group 4 
received the standard drug glibenclamide 5mg/kg p.o. 
Blood glucose were estimated before starting the treatment 
and weekly up to the 4th week. Blood cholesterol, 
triglyceride, aspartate transaminase, alanine transaminase, 
alkaline phosphatase, total protein, urea, creat inine and 
uric acid were determined at the end of the experiment.  
The drug was given once daily after determin ing 
hyperglycemia. Blood was drown in fasting condition from 
the tip of the tail and blood glucose level was estimated 
weekly till four week with the help of glucometer  using 
strip method. At the end of the experiment (at four week) 
blood sample were taken by retro orbital sinus under ether 
anesthesia by bleeding method for measuring various 
biochemical parameter ment ioned as above. 
STATISTICAL ANALYS IS  
Results were expressed as mean with standard deviation. 
The data were analyzed using analysis of variance 
(ANOVA). Group means were compared by Post Hoc test. 
Values were considered statistically significant with p ≤ 
0.05. 
RES ULTS  
Acute toxicity studies  
 Acute toxicity studies revealed the nontoxic nature of the 
ethanolic extract of H. antidysenterica. It did not produce 
changes in behavior, and general activity of the animal at 
3000 mg/kg dose.  All the animals were alive, healthy and 
active during the observation period. No death was 
observed at this dose. The fact that the LD50 of ethanolic 
extract of H. antidysenterica is above 3000 mg/kg is an 
indication that the extract could be considered relatively  
safe, when given orally. 
Oral glucose tolerance test 
EHA significantly reduced plasma glucose levels ½ hr 
after admin istration of glucose in euglycemic rats (Table 
1). 
Table 1: Effect of ethanolic ext ract of H. antidysenterica seeds on oral glucos e tolerance test in normal rats  
Group 0 hr. (mg/dl) ½ hr. (mg/dl) 1 hr. (mg/dl) 2 hr. (mg/dl) 
Vehicle(Distilled water 10ml/kg) 76.5±2.51 92±2.83 103±3.34 87±0.89 
EHA(300mg/kg) 78±3.22 88.67±2.66 96.33±3.83 79.67±3.5 
EHA2(600mg/kg) 80.16±2.99 90.33±3.01 99.17±2.04 80±2.13 
GLB(5mg/kg) 81.33±2.34 89±4.2 93.83±5.08 74±1.41 
Values are mean ± SD of 6 rats in each group. *P < 0.05 when compared with vehicle-treated group (Post hoc test). 
Changes in Body Weight 
Diabetic rats showed a decrease in body weight during the 
experimental period. 21.94% decrease was noted at the end 
of 4
th
 week. H. antidysenterica and glibenclamide treated 
diabetic group rat showed significant increase in weight. 
Percentage increase in body weight in these (H. 
antidysenterica 300 and 600mg/kg b.w and glibenclamide) 
treated group were respectively 24.75, 24.66 and 27.51 in  
four weeks (Table 2). 
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TABLE 2: Effect of ethanolic extract of H. Antidysenterica seed on body weight of diabetic rats 
Group 0 Week 1 Week 2Week 3Week 4Week 
DC 132.17±7.03 127±7.03 120.83±6.98     111.83±5.83 103.17±3.97 
EHA1 136.67±5.20 143.67±6.65  151.5±5.47 159.5±3.73 170.5±2.51 
EHA2 133.67±7.08 143.67±6.65 153±6.20 161.33±5.57 166.83±3.82 
GLB 131.5±7.04 138.5±7.42 146.83±7.76 153.5±10.25 167.67±7.23 
Mean body weight (g) of diabetic control (DC), ethanolic extract of H.antidysenterica seeds 300 and 600mg/kg (EHA1 & EHA2) and glibenclamide 
5mg/kg (GLB) treated group albino rats during the experimental period. Values are mean ± SD of 6 rats in each group. *P <0.001 when compared 
with diabetic-control group (Post hoc test). 
Blood glucose level 
After streptozotocin injection all the rats developed 
diabetes and blood glucose level was at about 330 mg/dl.  
Significant reduction (P < 0.05) in blood glucose levels 
was observed weekly in EHA treated diabetic rats (in a 
dose of 300 and 600mg/kg) (Table 3). The decrease in  
blood glucose level in EHA treated group was less in 
comparison to glibenclamide treated rats.  
 
Table 3: Effect of ethanolic ext ract of H.antidysenterica seeds on STZ induced diabetic rats 
Group  0 days  7 days  14 days   21 days 28 days 
Diabetic Control 329.5±13.46 334.33±6.62 327.33±5.28 327.5±10.82 334.5±7.09 
EHA1 treated 329.33±8.76 210.5±28.82 179±10.20 152.67±10.5 133.67±6.71 
EHA2 treated 328.33±8.74 244.83±11.2 171±9.36 139.5±20.96 133±3.35 
GLB Treated 332.83±6.01 231.17±8.99 163.83±16.15 119.67±11.81 88.67±2.16 
Mean fasting blood glucose level (mg/dl) of diabetic control, ethanolic extract 300 and 600mg/kg (EHA1 & EHA2) and glibenclamide 5mg/kg (GLB) 
treated group albino rats during the experimental period. Values are mean ± SD, n=6 in each group. *P < 0.001 when compared with diabetic control 
rats (Post Hoc test). 
Effect on biochemical parameters  
Administration of Ethanolic extract of H. antidysenterica 
in 300, and 600 mg/kg dose for 4 weeks significantly  
decreased the total cholesterol (P < 0.001) and trig lyceride 
(p < 0.001) level in albino rats in comparison to diabetic 
control rats [Table 4].  
A significant decrease in AST (P < 0.05), ALT (P < 
0.001), urea (P < 0.05), and serum creatinine(P < 0.05) 
level was found in EHA (in both 300 and 600mg/kg dose) 
treated diabetic rats. Total plasma protein was significantly  
maintained in EHA treated rat.  
Table 4: The effect of the ethanolic extract of H.antidysenterica seed on biomedical parameters  
 DC EHA1 EHA2 GLB 
Cholesterol(mg/dl) 140±3.41 84±1.41*  82±2*  87±3.74 
Trig lyceride(mg/dl) 182.50±4.23 140±6.23* 136.83±5.67*  100±2.53 
AST(U/L) 65.33±3.78 45±2.28*  46±2.9 43±2.37 
ALT(U/L) 49±5.44 43±2.1˚ 47±3.46 39±2 
ALK(U/L) 188.5±5.13 167.83±4.9* 172.50±4.2* 166±3.95 
Total protein(mg/dl) 4.4±0.28 7.90±0.01˚ 8.2±0.05*  7.83±0.02 
Blood urea(mg/dl) 0.48±0.02 0.35±0.05 0.38±0.08*  0.32±0.12 
Creat inine(mg/dl) 2.91±0.16 2.32±0.29 2.48±0.19˚ 2.28±0.29 
Uric acid(mg/dl) 2.48±0.19 2.55±0.15 2.32±0.29 2.28±0.29 
The effect of the ethanolic extract of H.antidysenterica seed on biochemical parameters of diabetic control (DC), ethanolic extract EHA 300 and 
600mg/kg (EHA1 & EHA2) and glibenclamide 5mg/kg (GLB) treated group albino rats during the experimental period.  Data are expressed as mean 
± SD. (N = 6).*P < 0.001, ˚P < 0.05 when compared to diabetic control rats. 
DISCUSS ION   
In glucose tolerance test a significant reduction in plasma 
glucose levels was found in EHA treated euglyce mic rat  
when it was compared to normal control rats. It is probably 
due to its antihyperglycemic effect by retarding the 
carbohydrate absorption from intestine through the 
inhibit ionin in α- glucosidase activity.12           
This study shows the efficacy of EHA seed in  
streptozotocin induced diabetic rats. Semiliar results of the 
methanolic extract o f this plant seeds were reported by 
mana et al
13
. STZ caused the destruction of pancreatic β 
cells in alb ino rats. Consequences to it animals developed 
marked hyperglycemia. Over production of glucose and 
decreased utilization by the tissues is the fundamental 
basis of hyperglycemia in diabetes mellitus. The possible 
hypoglycemic activity by EHA may be through 
potentiating action on β cell of islets or stimulat ion of 
blood glucose uptake by peripheral tissue or/and inhibition 
of endogenous glucose production or activation of 
gluconeogenesis in liver and muscles
14
. 
Decrease in body weight in streptozotocin induced diabetic 
rats and weight gain in EHA treated group (table 2) is due 
to loss of tissue protein
15
 and muscle wasting in the former 
and having beneficial effect in preventing loss of body 
weight and in catabolic process in EHA treated groups. 
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Significant increase in weight in  EHA treated group of 
albino rats in comparison to vehicle treated diabetic rats 
indicating that ethanolic extract of H. antidysenterica had 
beneficial effect in preventing loss of body weight of 
diabetic rats.  
Insulin deficiency leads to various metabolic abnormalit ies 
in animals
16, 17
. Increased ALT, AST, alkaline phosphates, 
serum cholesterol, serum t rig lyceride and decreased total 
protein are indication of these abnormalities. Restoration 
of the level of biochemical enzymes in H. antidysenterica 
and glibenclamide treated alb ino rats are indication of 
better control of blood sugar level in this group.  
CONCLUS ION 
The ethanolic extract of H. antidysenterica seed has 
antihyperglycemic activity as it lowers serum glucose level 
in diabetic albino rats and significantly increases glucose 
tolerance. It prevents weight loss in diabetic rats and 
corrects altered biochemical parameters e.g.  serum 
cholesterol, triglyceride, aspartate transaminase, alanine 
transaminase, alkaline transferase, total protein, urea, 
creatinine and uric acid  to near normal physiological 
range. This is an indication of its better metabolic control 
and potent antidiabetic property. Hence, further studies are 
required to know the exact mechanis m of action and 
compound responsible for antidiabetic effect.  
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